Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2010 (2010), Article ID 621870, 11 pages
http://dx.doi.org/10.4061/2010/621870
Review Article

Alzheimer's Proteins, Oxidative Stress, and Mitochondrial Dysfunction Interplay in a Neuronal Model of Alzheimer's Disease

Istituto di Biomembrane e Bioenergetica, CNR, Via Amendola 165/A, 70126 Bari, Italy

Received 14 April 2010; Revised 24 June 2010; Accepted 9 July 2010

Academic Editor: Gemma Casadesus

Copyright © 2010 Antonella Bobba et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. P. Mattson, “Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders,” Antioxidants & Redox Signaling, vol. 8, no. 11-12, pp. 1997–2006, 2006. View at Google Scholar · View at Scopus
  2. C. Culmsee and S. Landshamer, “Molecular insights into mechanisms of the cell death programml: role in the progression of neurodegenerative disorders,” Current Alzheimer Research, vol. 3, no. 4, pp. 269–283, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Nunomura, P. I. Moreira, H. G. Lee, X. Zhu, R. J. Castellani, M. A. Smith, and G. Perry, “Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases,” CNS & Neurological Disorders—Drug Targets, vol. 6, no. 6, pp. 411–423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. S. Honig and R. N. Rosenberg, “Apoptosis and neurologic disease,” The American Journal of Medicine, vol. 108, no. 4, pp. 317–330, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Eckert, C. A. Marques, U. Keil, K. Schüssel, and W. E. Müller, “Increased apoptotic cell death in sporadic and genetic Alzheimer's Disease,” Annals of the New York Academy of Sciences, vol. 1010, pp. 604–609, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. T. T. Rohn and E. Head, “Caspase activation in Alzheimer's disease: early to rise and late to bed,” Reviews in the Neurosciences, vol. 19, no. 6, pp. 383–393, 2008. View at Google Scholar · View at Scopus
  7. C. Schwab, M. Hosokawa, and P. L. McGeer, “Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease,” Experimental Neurology, vol. 188, no. 1, pp. 52–64, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. N. Canu and P. Calissano, “In vitro cultured neurons for molecular studies correlating apoptosis with events related to Alzheimer disease,” Cerebellum, vol. 2, no. 4, pp. 270–278, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. P. Calissano, C. Matrone, and G. Amadoro, “Apoptosis and in vitro Alzheimer disease neuronal models,” Communitative & Integrative Biology, vol. 2, no. 2, pp. 163–169, 2009. View at Google Scholar · View at Scopus
  10. S. Cicconi, A. Gentile, M. T. Ciotti, T. Parasassi, A. Serafino, and P. Calissano, “Apoptotic death induces Aβ production and fibril formation to a much larger extent than necrotic-like death in CGNs,” Journal of Alzheimer's Disease, vol. 12, no. 3, pp. 211–220, 2007. View at Google Scholar · View at Scopus
  11. V. Gallo, M. T. Ciotti, F. Aloisi, and G. Levi, “Developmental features of rat cerebellar neural cells cultured in a chemically defined medium,” Journal of Neuroscience Research, vol. 15, no. 3, pp. 289–301, 1986. View at Google Scholar · View at Scopus
  12. S. R. D'Mello, C. Galli, T. Ciotti, and P. Calissano, “Induction of apoptosis in cerebellar granule neurons by low potassiumml: inhibition of death by insulin-like growth factor I and cAMP,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 10989–10993, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Galli, O. Meucci, A. Scorziello, T. M. Werge, P. Calissano, and G. Schettini, “Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis,” Journal of Neuroscience, vol. 15, no. 2, pp. 1172–1179, 1995. View at Google Scholar · View at Scopus
  14. L. B. Rosen, D. D. Ginty, M. J. Weber, and M. E. Greenberg, “Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras,” Neuron, vol. 12, no. 6, pp. 1207–1221, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Bobba, A. Atlante, L. de Bari, S. Passarella, and E. Marra, “Apoptosis and cytochrome c release in cerebellar granule cells,” In Vivo, vol. 18, no. 3, pp. 335–344, 2004. View at Google Scholar · View at Scopus
  16. A. Atlante, S. Gagliardi, E. Marra, and P. Calissano, “Neuronal apoptosis in rats is accompanied by rapid impairment of cellular respiration and is prevented by scavengers of reactive oxygen species,” Neuroscience Letters, vol. 245, no. 3, pp. 127–130, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Atlante and S. Passarella, “Detection of reactive oxygen species in primary cultures of cerebellar granule cells,” Brain Research Protocols, vol. 4, no. 3, pp. 266–270, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Atlante, A. Bobba, P. Calissano, S. Passarella, and E. Marra, “The apoptosis/necrosis transition in cerebellar granule cells depends on the mutual relationship of the antioxidant and the proteolytic systems which regulate ROS production and cytochrome c release en route to death,” Journal of Neurochemistry, vol. 84, no. 5, pp. 960–971, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Bobba, A. Atlante, L. Moro, P. Calissano, and E. Marra, “Nitric oxide has dual opposite roles during early and late phases of apoptosis in cerebellar granule neurons,” Apoptosis, vol. 12, no. 9, pp. 1597–1610, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. A. Bobba, A. Atlante, V. A. Petragallo, and E. Marra, “Different sources of reactive oxygen species contribute to low potassium-induced apoptosis in cerebellar granule cells,” International Journal of Molecular Medicine, vol. 21, no. 6, pp. 737–745, 2008. View at Google Scholar · View at Scopus
  21. A. Atlante, P. Calissano, A. Bobba, A. Azzariti, E. Marra, and S. Passarella, “Cytochrome c is released from mitochondria in a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic death,” Journal of Biological Chemistry, vol. 275, no. 47, pp. 37159–37166, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A. Atlante, L. De Bari, A. Bobba, E. Marra, P. Calissano, and S. Passarella, “Cytochrome c, released from cerebellar granule cells undergoing apoptosis or excytotoxic death, can generate protonmotive force and drive ATP synthesis in isolated mitochondria,” Journal of Neurochemistry, vol. 86, no. 3, pp. 591–604, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Bobba, A. Atlante, S. Giannattasio, G. Sgaramella, P. Calissano, and E. Marra, “Early release and subsequent caspase-mediated degradation of cytochrome c in apoptotic cerebellar granule cells,” FEBS Letters, vol. 457, no. 1, pp. 126–130, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Bobba, N. Canu, A. Atlante, V. Petragallo, P. Calissano, and E. Marra, “Proteasome inhibitors prevent cytochrome c release during apoptosis but not in excitotoxic death of cerebellar granule neurons,” FEBS Letters, vol. 515, no. 1–3, pp. 8–12, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Atlante, S. Giannattasio, and S. Giannattasio, “An increase in the ATP levels occurs in cerebellar granule cells en route to apoptosis in which ATP derives from both oxidative phosphorylation and anaerobic glycolysis,” Biochimica et Biophysica Acta, vol. 1708, no. 1, pp. 50–62, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. Atlante, A. Bobba, L. de Bari, F. Fontana, P. Calissano, E. Marra, and S. Passarella, “Caspase-dependent alteration of the ADP/ATP translocator triggers the mitochondrial permeability transition which is not required for the low-potassium-dependent apoptosis of cerebellar granule cells,” Journal of Neurochemistry, vol. 97, no. 4, pp. 1166–1181, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. C. Galli, A. Piccini, M. T. Ciotti, L. Castellani, P. Calissano, D. Zaccheo, and M. Tabaton, “Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 3, pp. 1247–1252, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Canu, L. Dus, and L. Dus, “Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis,” Journal of Neuroscience, vol. 18, no. 18, pp. 7061–7074, 1998. View at Google Scholar · View at Scopus
  29. G. Amadoro, A. L. Serafino, C. Barbato, M. T. Ciotti, A. Sacco, P. Calissano, and N. Canu, “Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons,” Cell Death & Differentiation, vol. 11, no. 2, pp. 217–230, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. A. Atlante, G. Amadoro, and G. Amadoro, “A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator,” Biochimica et Biophysica Acta, vol. 1777, no. 10, pp. 1289–1300, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. E. H. Koo, “The β-amyloid precursor protein (APP) and alzheimer's disease: does the tail wag the dog?” Traffic, vol. 3, no. 11, pp. 763–770, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Goedert, M. G. Spillantini, R. Jakes, D. Rutherford, and R. A. Crowther, “Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease,” Neuron, vol. 3, no. 4, pp. 519–526, 1989. View at Google Scholar · View at Scopus
  33. C. Barbato, N. Canu, and N. Canu, “Interaction of Tau with Fe65 links tau to APP,” Neurobiology of Disease, vol. 18, no. 2, pp. 399–408, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. S. Kesavapany, S. J. Banner, K.-F. Lau, C. E. Shaw, C. C. J. Miller, J. D. Cooper, and D. M. McLoughlin, “Expression of the Fe65 adapter protein in adult and developing mouse brain,” Neuroscience, vol. 115, no. 3, pp. 951–960, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Scorziello, O. Meucci, T. Florio, M. Fattore, G. Forloni, M. Salmona, and G. Schettini, “β25-35 alters calcium homeostasis and induces neurotoxicity in cerebellar granule cells,” Journal of Neurochemistry, vol. 66, no. 5, pp. 1995–2003, 1996. View at Google Scholar · View at Scopus
  36. B. A. Yankner, L. R. Dawes, S. Fisher, L. Villa-Komaroff, M. L. Oster-Granite, and R. L. Neve, “Neurotixicity of a fragment of the amyloid precursor associated with Alzheimer's disease,” Science, vol. 245, no. 4916, pp. 417–420, 1989. View at Google Scholar · View at Scopus
  37. D. M. Hartley, D. M. Walsh, and D. M. Walsh, “Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons,” Journal of Neuroscience, vol. 19, no. 20, pp. 8876–8884, 1999. View at Google Scholar · View at Scopus
  38. D. M. Walsh and D. J. Selkoe, “Deciphering the molecular basis of memory failure in Alzheimer's disease,” Neuron, vol. 44, no. 1, pp. 181–193, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. G. M. Shankar, B. L. Bloodgood, M. Townsend, D. M. Walsh, D. J. Selkoe, and B. L. Sabatini, “Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway,” Journal of Neuroscience, vol. 27, no. 11, pp. 2866–2875, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. J. W. Allen, B. A. Eldadah, X. Huang et al., “Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis,” Journal of Neuroscience Research, vol. 65, no. 1, pp. 45–53, 2001. View at Google Scholar
  41. F. Misiti, M. E. Clementi, and M. E. Clementi, “Fragment 31-35 of β-amyloid peptide induces neurodegeneration in rat cerebellar granule cells via bax gene expression and caspase-3 activation. A crucial role for the redox state of methionine-35 residue,” Neurochemistry International, vol. 49, no. 5, pp. 525–532, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. A. Pannaccione, F. Boscia, and F. Boscia, “Up-regulation and increased activity of KV3.4 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death,” Molecular Pharmacology, vol. 72, no. 3, pp. 665–673, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. L. D. Plant, N. J. Webster, J. P. Boyle, M. Ramsden, D. B. Freir, C. Peers, and H. A. Pearson, “Amyloid β peptide as a physiological modulator of neuronal 'A'-type K+ current,” Neurobiology of Aging, vol. 27, no. 11, pp. 1673–1683, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. M. Pieri, G. Amadoro, and G. Amadoro, “SP protects cerebellar granule cells against β-amyloid-induced apoptosis by down-regulation and reduced activity of Kv4 potassium channels,” Neuropharmacology, vol. 58, no. 1, pp. 268–276, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. T. T. Rohn, R. A. Rissman, M. C. Davis, Y. E. Kim, C. W. Cotman, and E. Head, “Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain,” Neurobiology of Disease, vol. 11, no. 2, pp. 341–354, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Fasulo, G. Ugolini, and G. Ugolini, “The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis,” Journal of Neurochemistry, vol. 75, no. 2, pp. 624–633, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. C.-W. Chung, Y.-H. Song, and Y.-H. Song, “Proapoptotic effects of tau cleavage product generated by caspase-3,” Neurobiology of Disease, vol. 8, no. 1, pp. 162–172, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. G. Amadoro, M. T. Ciotti, M. Costanzi, V. Cestari, P. Calissano, and N. Canu, “NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2892–2897, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. K. Leuner, S. Hauptmann, and S. Hauptmann, “Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?” Antioxidants and Redox Signaling, vol. 9, no. 10, pp. 1659–1675, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. V. Rhein, G. Baysang, S. Rao, F. Meier, A. Bonert, F. Müller-Spahn, and A. Eckert, “Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells,” Cellular and Molecular Neurobiology, vol. 29, no. 6-7, pp. 1063–1071, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. M. Mancuso, F. Coppedè, L. Murri, and G. Siciliano, “Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality?” Antioxidants & Redox Signaling, vol. 9, no. 10, pp. 1631–1646, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. W. D. Parker Jr., C. M. Filley, and J. K. Parks, “Cytochrome oxidase deficiency in Alzheimer's disease,” Neurology, vol. 40, no. 8, pp. 1302–1303, 1990. View at Google Scholar · View at Scopus
  53. K. Tieu, C. Perier, and C. Perier, “L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease,” Annals of Neurology, vol. 56, no. 1, pp. 51–60, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. S. M. Cardoso, I. Santana, R. H. Swerdlow, and C. R. Oliveira, “Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity,” Journal of Neurochemistry, vol. 89, no. 6, pp. 1417–1426, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. F. Bosetti, F. Brizzi, and F. Brizzi, “Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease,” Neurobiology of Aging, vol. 23, no. 3, pp. 371–376, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Mancuso, M. Filosto, and M. Filosto, “Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease,” Experimental Neurology, vol. 182, no. 2, pp. 421–426, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Eckert, K .L. Schulz, V. Rhein et al., “Convergence of amyloid-beta and tau pathologies on mitochondria in vivo,” Molecular Neurobiology, vol. 41, no. 2-3, pp. 107–114, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. P. H. Reddy, “Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons,” Antioxidants & Redox Signaling, vol. 9, no. 10, pp. 1647–1658, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. P. H. Reddy, “Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease,” Experimental Neurology, vol. 218, no. 2, pp. 286–292, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. X. Chen and S. D. Yan, “Mitochondrial Aβ: a potential cause of metabolic dysfunction in Alzheimer's disease,” IUBMB Life, vol. 58, no. 12, pp. 686–694, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. F. M. LaFerla, K. N. Green, and S. Oddo, “Intracellular amyloid-β in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 8, no. 7, pp. 499–509, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. C. A. Hansson Petersen, N. Alikhani, and N. Alikhani, “The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13145–13150, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. L. Saavedra, A. Mohamed, V. Ma, S. Kar, and E. P. De Chaves, “Internalization of β-amyloid peptide by primary neurons in the absence of apolipoprotein E,” Journal of Biological Chemistry, vol. 282, no. 49, pp. 35722–35732, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. K. E. Muirhead, E. Borger, L. Aitken, S. J. Conway, and F.J. Gunn-Moore, “The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease,” Biochemical Journal, vol. 426, no. 3, pp. 255–270, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. C. Caspersen, N. Wang, and N. Wang, “Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease,” The FASEB Journal, vol. 19, no. 14, pp. 2040–2041, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. H. Du and S. S. Yan, “Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta,” Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 198–204, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. P. Singh, S. Suman, S. Chandna et al., “Possible role of amyloid-beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer's disease,” Bioinformation, vol. 3, no. 10, pp. 440–445, 2009. View at Google Scholar
  68. R. A. Quintanilla, T. A. Matthews-Roberson, P. J. Dolan, and G. V. W. Johnsion, “Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of alzheimer disease,” Journal of Biological Chemistry, vol. 284, no. 28, pp. 18754–18766, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. T. T. Rohn, E. Head, J. H. Su, A. J. Anderson, B. A. Bahr, C. W. Cotman, and D. H. Cribbs, “Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease,” American Journal of Pathology, vol. 158, no. 1, pp. 189–198, 2001. View at Google Scholar · View at Scopus
  70. M. C. Gastard, J. C. Troncoso, and V. E. Koliatsos, “Caspase activation in the limbic cortex of subjects with early Alzheimer's disease,” Annals of Neurology, vol. 54, no. 3, pp. 393–398, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. J. L. Dinerman, T. M. Dawson, M. J. Schell, A. Snowman, and S. H. Snyder, “Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 10, pp. 4214–4218, 1994. View at Google Scholar · View at Scopus
  72. M. Zhuo, E. R. Kandel, and R. D. Hawkins, “Nitric oxide and cGMP can produce either synaptic depression or potentiation depending on the frequency of presynaptic stimulation in the hippocampus,” Neuroreport, vol. 5, no. 9, pp. 1033–1036, 1994. View at Google Scholar · View at Scopus
  73. G. R. J. Thatcher, B. M. Bennett, and J. N. Reynolds, “NO chimeras as therapeutic agents in Alzheimer's disease,” Current Alzheimer Research, vol. 3, no. 3, pp. 237–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. D. Puzzo, O. Vitolo, F. Trinchese, J. P. Jacob, A. Palmeri, and O. Arancio, “Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity,” Journal of Neuroscience, vol. 25, no. 29, pp. 6887–6897, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. M. F. McCarty, “Toward prevention of alzheimers disease—potential nutraceutical strategies for suppressing the production of amyloid beta peptides,” Medical Hypotheses, vol. 67, no. 4, pp. 682–697, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. T. Pak, P. Cadet, K. J. Mantione, and G. B. Stefano, “Morphine via nitric oxide modulates β-amyloid metabolismml: a novel protective mechanism for Alzheimer's disease,” Medical Science Monitor, vol. 11, no. 10, pp. BR357–BR366, 2005. View at Google Scholar · View at Scopus
  77. D. Seyidova, A. Aliyev, and A. Aliyev, “The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease,” In Vivo, vol. 18, no. 3, pp. 325–334, 2004. View at Google Scholar · View at Scopus
  78. H. J. Lüth, M. Holzer, H.-J. Gertz, and TH. Arendt, “Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21(ras) and p16(INK4a),” Brain Research, vol. 852, no. 1, pp. 45–55, 2000. View at Publisher · View at Google Scholar · View at Scopus
  79. S. M. de la Monte, B.-X. Lu, Y.-K. Sohn, D. Etienne, J. Kraft, N. Ganju, and J. R. Wands, “Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration,” Neurobiology of Aging, vol. 21, no. 2, pp. 309–319, 2000. View at Publisher · View at Google Scholar · View at Scopus
  80. M. H. Tran, K. Yamada, A. Olariu, M. Mizuno, X. H. Ren, and T. Nabeshima, “Amyloid β-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors,” The FASEB Journal, vol. 15, no. 8, pp. 1407–1409, 2001. View at Google Scholar · View at Scopus
  81. J. Haas, B. Storch-Hagenlocher, A. Biessmann, and B. Wildemann, “Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with β-amyloid 1–42 in vitro,” Neuroscience Letters, vol. 322, no. 2, pp. 121–125, 2002. View at Google Scholar · View at Scopus
  82. M. YU. Stepanichev, M. V. Onufriev, and M. V. Onufriev, “Amyloid-β (25–35) increases activity of neuronal NO-synthase in rat brain,” Neurochemistry International, vol. 52, no. 6, pp. 1114–1124, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. U. Keil, A. Bonert, and A. Bonert, “Amyloid β-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis,” Journal of Biological Chemistry, vol. 279, no. 48, pp. 50310–50320, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. K.-S. Ha, K.-M. Kim, and K.-M. Kim, “Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation,” The FASEB Journal, vol. 17, no. 9, pp. 1036–1047, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. S. M. de la Monte and J. R. Wands, “Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 9, no. 2, pp. 167–181, 2006. View at Google Scholar · View at Scopus
  86. H. Yuan, A. A. Gerencser, G. Liot, S. A. Lipton, M. Ellisman, G. A. Perkins, and E. Bossy-Wetzel, “Mitochondrial fission is an upstream and required event for bax foci formation in response to nitric oxide in cortical neurons,” Cell Death and Differentiation, vol. 14, no. 3, pp. 462–471, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. M. J. Barsoum, H. Yuan, and H. Yuan, “Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons,” The EMBO Journal, vol. 25, no. 16, pp. 3900–3911, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. D.-H. Cho, T. Nakamura, J. Fang, P. Cieplak, A. Godzik, Z. Gu, and S. A. Lipton, “S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury,” Science, vol. 324, no. 5923, pp. 102–105, 2009. View at Google Scholar
  89. Z. Gu, T. Nakamura, and S. A. Lipton, “Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases,” Molecular Neurobiology, vol. 41, no. 2-3, pp. 55–72, 2010. View at Google Scholar
  90. B. Bossy, A. Petrilli, E. Klinglmayr et al., “S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 20, no. 2, pp. 513–526, 2010. View at Google Scholar
  91. A. Jahani-Asl, E. C. C. Cheung, and E. C. C. Cheung, “Mitofusin 2 protects cerebellar granule neurons against injury-induced cell death,” Journal of Biological Chemistry, vol. 282, no. 33, pp. 23788–23798, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. B. Su, X. Wang, L. Zheng, G. Perry, M. A. Smith, and X. Zhu, “Abnormal mitochondrial dynamics and neurodegenerative diseases,” Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 135–142, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. A. Nunomura, R. J. Castellani, X. Zhu, P. I. Moreira, G. Perry, and M. A. Smith, “Involvement of oxidative stress in Alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 65, no. 7, pp. 631–641, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. B. Su, X. Wang, and X. Wang, “Oxidative stress signaling in Alzheimer's disease,” Current Alzheimer Research, vol. 5, no. 6, pp. 525–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Jana and K. Pahan, “Fibrillar amyloid-β peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase:implications for Alzheimer's disease,” Journal of Biological Chemistry, vol. 279, no. 49, pp. 51451–51459, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. P. B. Shelat, M. Chalimoniuk, and M. Chalimoniuk, “Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons,” Journal of Neurochemistry, vol. 106, no. 1, pp. 45–55, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. M. A. Smith, P. L. Richey Harris, L. M. Sayre, J. S. Beckman, and G. Perry, “Widespread peroxynitrite-mediated damage in Alzheimer's disease,” Journal of Neuroscience, vol. 17, no. 8, pp. 2653–2657, 1997. View at Google Scholar · View at Scopus
  98. M. R. Reynolds, J. F. Reyes, Y. Fu, E. H. Bigio, A. L. Guillozet-Bongaarts, R. W. Berry, and L. I. Binder, “Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies,” Journal of Neuroscience, vol. 26, no. 42, pp. 10636–10645, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. Y.-J. Zhang, Y.-F. Xu, Y.-H. Liu, J. Yin, H.-A. Li, Q. Wang, and J.-Z. Wang, “Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms,” The FASEB Journal, vol. 20, no. 9, pp. 1431–1442, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. T. Horiguchi, K. Uryu, and K. Uryu, “Nitration of tau protein is linked to neurodegeneration in tauopathies,” American Journal of Pathology, vol. 163, no. 3, pp. 1021–1031, 2003. View at Google Scholar · View at Scopus
  101. C. J. Pike, J. C. Carroll, E. R. Rosario, and A. M. Barron, “Protective actions of sex steroid hormones in Alzheimer's disease,” Frontiers in Neuroendocrinology, vol. 30, no. 2, pp. 239–258, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  102. J. E. Rossouw, G. L. Anderson, and G. L. Anderson, “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial,” Journal of the American Medical Association, vol. 288, no. 3, pp. 321–333, 2002. View at Google Scholar · View at Scopus
  103. G. Perry, A. D. Cash, and M. A. Smith, “Alzheimer disease and oxidative stress,” Journal of Biomedicine and Biotechnology, vol. 2002, no. 3, pp. 120–123, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  104. O. Y. Bang, H. S. Hong, D. H. Kim, H. Kim, J. H. Boo, K. Huh, and I. Mook-Jung, “Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity,” Neurobiology of Disease, vol. 16, no. 1, pp. 21–28, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  105. H. Zeng, Q. Chen, and B. Zhao, “Genistein ameliorates β-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis,” Free Radical Biology and Medicine, vol. 36, no. 2, pp. 180–188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. N. J. Linford and D. M. Dorsa, “17β-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin,” Steroids, vol. 67, no. 13-14, pp. 1029–1040, 2002. View at Publisher · View at Google Scholar · View at Scopus
  107. J. M. Andersen, O. Myhre, and F. Fonnum, “Discussion of the role of the extracellular signal-regulated kinase-phospholipase A2 pathway in production of reactive oxygen species in Alzheimer's disease,” Neurochemical Research, vol. 28, no. 2, pp. 319–326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  108. H.-L. Yu, L. Li, X.-H. Zhang, L. Xiang, J. Zhang, J.-F. Feng, and R. Xiao, “Neuroprotective effects of genistein and folic acid on apoptosis of rat cultured cortical neurons induced by beta-amyloid 31-35,” British Journal of Nutrition, vol. 102, no. 5, pp. 655–662, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  109. Y.-J. Park, Y.-M. Jang, and Y. H. Kwon, “Isoflavones prevent endoplasmic reticulum stress-mediated neuronal degeneration by inhibiting tau hyperphosphorylation in SH-SY5Y Cells,” Journal of Medicinal Food, vol. 12, no. 3, pp. 528–535, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. A. Atlante, A. Bobba, G. Paventi, R. Pizzuto, and S. Passarella, “Genistein and daidzein prevent low potassium-dependent apoptosis of cerebellar granule cells,” Biochemical Pharmacology, vol. 79, no. 5, pp. 758–767, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  111. S. L. Vallés, C. Borrás, and C. Borrás, “Oestradiol or genistein rescues neurons from amyloid beta-induced cell death by inhibiting activation of p38,” Aging Cell, vol. 7, no. 1, pp. 112–118, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  112. Q. Cai and H. Wei, “Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice,” Nutrition and Cancer, vol. 25, no. 1, pp. 1–7, 1996. View at Google Scholar · View at Scopus
  113. P. Foti, D. Erba, P. Riso, A. Spadafranca, F. Criscuoli, and G. Testolin, “Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes,” Archives of Biochemistry and Biophysics, vol. 433, no. 2, pp. 421–427, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus